Multimarker surface signatures of human islet derived extracellular vesicles - we propose an industrial-academic collaboration in response to RFA-DK-21-016 titled "characterization of islet- derived…

Active Project Grant Awarded Last action

Award ID
R01DK133861
Recipient
Awarding agency
Obligated
$5,555,842

Award facts

Completion date 87% complete
Originally
Place of performance
MONTGOMRY VLG, MD 20877, USA

Award details come from USAspending.gov.

Description

Multimarker surface signatures of human islet derived extracellular vesicles - we propose an industrial-academic collaboration in response to RFA-DK-21-016 titled "characterization of islet- derived extracellular vesicles for improved detection, monitoring, classification, and treatment of type 1 diabetes". The objectives are to identify combinations of surface markers that define populations of EV originating from the major cells of the islets of langerhans and exocrine pancreatic tissue and to apply novel technologies for isolating and deeply characterizing these unique EV populations. We will build upon recent successes at MSD in developing a novel technique for EV surface marker screening and a multimarker immunoaffinity technique for isolating highly specific EV populations. These techniques will be adapted to the specific EV populations of the pancreas, which will enable US to observe changes to the EV repertoire related to pathological events and to identify populations of EVS or specific EV cargo that may serve as a remote biomarker for islet related events. We will apply our expertise in ultrasensitive ECL-based assays to develop assays that enable detection of these pancreas-specific EVS from peripheral blood. This proposal combines the technical expertise of meso scale diagnostics, LLC., with expertise in the biology of islet-derived extracellular vesicles of our collaborator, DR. Edward phelps at the university of florida.

Transactions

Action Obligated Date
Amendment $0
Amendment $691,014
Amendment $0
Amendment $701,224
Amendment $701,224
Amendment $0
Amendment $0
Amendment $0
Amendment $705,298
Amendment $705,298
Amendment $705,298
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment -$22,473
Amendment -$22,473
Amendment -$22,473
Amendment -$22,473
Amendment -$22,473
Amendment -$22,473
Amendment $740,662
Original award $740,662
Show all 23

Subawards

Subrecipient Amount Awarded
University Of Florida The project goals are to determine whether pancreas-derived EVs and their molecular cargo may be used as biomarkers of pancreatic dysfunction or cellular stress… $55,668

Quick answers

Who received award R01DK133861?

R01DK133861 was awarded to Meso Scale Diagnostics LLC by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 22, 2022.

How much is award R01DK133861 worth?

$5,555,842 has been obligated on R01DK133861.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award